Subcutaneous injection of tranexamic acid reduces postoperative bleeding following Mohs micrographic surgery: A single-institution cohort study

J Am Acad Dermatol. 2024 Sep;91(3):542-544. doi: 10.1016/j.jaad.2024.05.006. Epub 2024 May 9.

Authors

Nicole Loranger¹, Emily Karn¹, Jacob Anderson¹, Morgan Groover¹, David Wang¹, Chrysalyne Schmults¹, Emily Ruiz¹, Abigail Waldman²

Affiliations

¹ Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
² Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: [email protected].

PMID: 38734241
DOI: 10.1016/j.jaad.2024.05.006

No abstract available

Keywords: Mohs micrographic surgery (MMS); postoperative bleeding; postoperative complications.

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Antifibrinolytic Agents* / administration & dosage
Antifibrinolytic Agents* / therapeutic use
Cohort Studies
Female
Humans
Injections, Subcutaneous
Male
Middle Aged
Mohs Surgery* / adverse effects
Postoperative Hemorrhage* / etiology
Postoperative Hemorrhage* / prevention & control
Retrospective Studies
Skin Neoplasms* / surgery
Tranexamic Acid* / administration & dosage
Tranexamic Acid* / therapeutic use
Treatment Outcome

Substances

Tranexamic Acid
Antifibrinolytic Agents